Akèy › Kansè kanal bil (Kolangyokasinòm)
Etid klinik pou Kansè kanal bil (Kolangyokasinòm) ap rekrite nan Etazini
56 etid pou Kansè kanal bil (Kolangyokasinòm) ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX13 etid
- New York City, NY11 etid
- Boston, MA8 etid
- Rochester, MN7 etid
- Arlington, VA7 etid
- Los Angeles, CA7 etid
- Chicago, IL7 etid
- Columbus, OH6 etid
- Cleveland, OH6 etid
- Edison, NJ5 etid
- Queens, NY5 etid
- Grand Rapids, MI5 etid
- Nashville, TN5 etid
- San Antonio, TX5 etid
- Philadelphia, PA5 etid
- Tampa, FL5 etid
- Mountain View, CA5 etid
- Washington, DC5 etid
- Baldwin Park, CA5 etid
- Baltimore, MD5 etid
- Dallas, TX5 etid
- Miami, FL5 etid
- Orange, CA4 etid
- St. Louis, MO4 etid
- Durham, NC4 etid
- Seattle, WA4 etid
- Detroit, MI4 etid
- New Haven, CT4 etid
- Atlanta, GA3 etid
- West Valley City, UT3 etid
- Jacksonville, FL3 etid
- Salt Lake City, UT3 etid
- Buffalo, NY3 etid
- Birmingham, AL3 etid
- San Francisco, CA3 etid
- Louisville, KY3 etid
- Santa Monica, CA3 etid
Pa eta
- Alabama3 etid
- Arizona3 etid
- Colorado3 etid
- Connecticut6 etid
- Florid13 etid
- Georgia3 etid
- Illinois8 etid
- Kalifòni20 etid
- Kentucky4 etid
- Maryland9 etid
- Massachusetts10 etid
- Michigan8 etid
- Minnesota10 etid
- Missouri5 etid
- New Jersey8 etid
- New York15 etid
- North Carolina6 etid
- Ohio10 etid
- Pennsylvania5 etid
- Tennessee5 etid
- Texas15 etid
- Utah6 etid
- Virginia10 etid
- Washington4 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06728410Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03942328Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Ap rekriteEtid obsèvasyon
Laj 2 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT01915225A Study of PHST001 in Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06270706Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04645160PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Ap rekriteFaz 2
Laj 18 a 120 · Tout sèks · Mizajou Oct 1, 2026 · NCT05286814A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07265674[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07673341Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06302621Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Ap rekriteFaz 2
Laj 19 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07146646A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07488676Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06282575Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07780838Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 8, 2026 · NCT07282912Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05497531AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07619313Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04891289HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06899152Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07486713TCR1188-ABC Cells in KRAS-mutated Cancers
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07594067Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT05285358D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT06622057Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.